VEGFA and breast cancer: We describe below a case of advanced hormone receptor (HR)–positive BC benefitting from combination therapy using ATI with paclitaxel (PTX) plus the anti‐vascular endothelial growth factor (VEGF) antibody bevacizumab (BV).